DNX-2000

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDNX-2000
Drug Alias NameSYK kinase inhibitor (Dynamix/Teva Pharmaceutical)DNX-02000DNX-2000
ClassificationSmall molecules
Mechanisms of ActionSpleen tyrosine kinase inhibitorsImmunosuppressants
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDynamix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A